BACKGROUND: Defining cannabinoid stability in authentic oral fluid (OF) is critically important for result interpretation. There are few published OF stability data, and of those available, all employed fortified synthetic OF solutions or elution buffers; none included authentic OF following controlled cannabis smoking. METHODS: An expectorated OF pool and a pool of OF collected with Quantisal™ devices were prepared for each of 10 participants. Δ⁹-tetrahydrocannabinol (THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol (CBD), and cannabinol (CBN) stability in each of 10 authentic expectorated and Quantisal-collected OF pools were determined after storage at 4 °C for 1 and 4 weeks and at -20 °C for 4 and 24 weeks. Results within ±20% of baseline concentrations analyzed within 24 h of collection were considered stable. RESULTS: All Quantisal OF cannabinoid concentrations were stable for 1 week at 4 °C. After 4 weeks at 4 °C, as well as 4 and 24 weeks at -20 °C, THC was stable in 90%, 80%, and 80% and THCCOOH in 89%, 40%, and 50% of Quantisal samples, respectively. Cannabinoids in expectorated OF were less stable than in Quantisal samples when refrigerated or frozen. After 4 weeks at 4 and -20 °C, CBD and CBN were stable in 33%-100% of Quantisal and expectorated samples; by 24 weeks at -20 °C, CBD and CBN were stable in ≤ 44%. CONCLUSIONS: Cannabinoid OF stability varied by analyte, collection method, and storage duration and temperature, and across participants. OF collection with a device containing an elution/stabilization buffer, sample storage at 4 °C, and analysis within 4 weeks is preferred to maximize result accuracy.
BACKGROUND: Defining cannabinoid stability in authentic oral fluid (OF) is critically important for result interpretation. There are few published OF stability data, and of those available, all employed fortified synthetic OF solutions or elution buffers; none included authentic OF following controlled cannabis smoking. METHODS: An expectorated OF pool and a pool of OF collected with Quantisal™ devices were prepared for each of 10 participants. Δ⁹-tetrahydrocannabinol (THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol (CBD), and cannabinol (CBN) stability in each of 10 authentic expectorated and Quantisal-collected OF pools were determined after storage at 4 °C for 1 and 4 weeks and at -20 °C for 4 and 24 weeks. Results within ±20% of baseline concentrations analyzed within 24 h of collection were considered stable. RESULTS: All Quantisal OF cannabinoid concentrations were stable for 1 week at 4 °C. After 4 weeks at 4 °C, as well as 4 and 24 weeks at -20 °C, THC was stable in 90%, 80%, and 80% and THCCOOH in 89%, 40%, and 50% of Quantisal samples, respectively. Cannabinoids in expectorated OF were less stable than in Quantisal samples when refrigerated or frozen. After 4 weeks at 4 and -20 °C, CBD and CBN were stable in 33%-100% of Quantisal and expectorated samples; by 24 weeks at -20 °C, CBD and CBN were stable in ≤ 44%. CONCLUSIONS:Cannabinoid OF stability varied by analyte, collection method, and storage duration and temperature, and across participants. OF collection with a device containing an elution/stabilization buffer, sample storage at 4 °C, and analysis within 4 weeks is preferred to maximize result accuracy.
Authors: Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis Journal: Clin Chem Date: 2012-01-24 Impact factor: 8.327
Authors: Peter G Sacks; Zhong-Lin Zhao; Wieslawa Kosinska; Kenneth E Fleisher; Terry Gordon; Joseph B Guttenplan Journal: Food Chem Toxicol Date: 2011-06-21 Impact factor: 6.023
Authors: Dayong Lee; Garry Milman; Allan J Barnes; Robert S Goodwin; Jussi Hirvonen; Marilyn A Huestis Journal: Clin Chem Date: 2011-06-15 Impact factor: 8.327
Authors: M Vondracek; Z Xi; P Larsson; V Baker; K Mace; A Pfeifer; H Tjälve; M T Donato; M J Gomez-Lechon; R C Grafström Journal: Carcinogenesis Date: 2001-03 Impact factor: 4.944
Authors: Madeleine J Swortwood; Matthew N Newmeyer; Maria Andersson; Osama A Abulseoud; Karl B Scheidweiler; Marilyn A Huestis Journal: Drug Test Anal Date: 2016-10-13 Impact factor: 3.345
Authors: Sebastien Anizan; Garry Milman; Nathalie Desrosiers; Allan J Barnes; David A Gorelick; Marilyn A Huestis Journal: Anal Bioanal Chem Date: 2013-08-17 Impact factor: 4.142
Authors: Karl B Scheidweiler; Maria Andersson; Madeleine J Swortwood; Cristina Sempio; Marilyn A Huestis Journal: Drug Test Anal Date: 2016-09-13 Impact factor: 3.345
Authors: Kayla N Ellefsen; Marta Concheiro; Sandrine Pirard; David A Gorelick; Marilyn A Huestis Journal: Forensic Sci Int Date: 2016-01-22 Impact factor: 2.395
Authors: Matthew N Newmeyer; Nathalie A Desrosiers; Dayong Lee; Damodara R Mendu; Allan J Barnes; David A Gorelick; Marilyn A Huestis Journal: Drug Test Anal Date: 2014-03-20 Impact factor: 3.345
Authors: Sébastien Anizan; Mateus M Bergamaschi; Allan J Barnes; Garry Milman; Nathalie Desrosiers; Dayong Lee; David A Gorelick; Marilyn A Huestis Journal: Drug Test Anal Date: 2014-07-03 Impact factor: 3.345
Authors: Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis Journal: Drug Test Anal Date: 2015-08-10 Impact factor: 3.345